CR coming before big pharma??, page-2

An article from The Bull (dated 2 yrs ago but pertinent examples to CR's IMO) offering balanced views, examples and possible impacts / outcomes of CR's for anyone interested.

Frustrating at times when I see the mkt quite often view CR's as a negative in most cases and yes, sadly the mkt quite often reacts this way on the SP. It may be so when, as the Bull states, it is primarily debt reduction & corresponding dilution, but when viewing it more in line with funding growth etc, maybe we should see it as a positive?

From what I can see, the Co. appears to be debt free so any CR would be ongoing investment in getting the product commercialised I would have thought?

http://www.thebull.com.au/articles/a/29956-does-capital-raising-sound-the-bell-to-sell.html